Q32 Bio Inc.·4

Aug 14, 4:05 PM ET

TZIANABOS ARTHUR 4

4 · Q32 Bio Inc. · Filed Aug 14, 2024

Insider Transaction Report

Form 4
Period: 2024-03-25
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-25+1,0958,248 total
  • Sale

    Common Stock

    2024-03-25$24.20/sh265$6,4137,983 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-251,0950 total
    Common Stock (1,095 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer Common Stock.
  • [F2]The Issuer effected a 1-for-18 reverse stock split of its Common Stock on March 25, 2024. The amounts reported on this Form 4 have been adjusted to reflect the reverse stock split.
  • [F3]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
  • [F4]The restricted stock units vested in three equal installments, with the final installment vested on March 25, 2024. The restricted stock units had no expiration date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4